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FIGURE 1 Angiographic and OCT Images of LAD-Dg and LMCA Bifurcations
Follow-up angiograms show excellent results in the LAD-Dg bifurcation lesion treated with a bioresorbable vascular scaffold (BVS) (red dotted
line) in the LAD and an everolimus-eluting stent (EES) (yellow dotted line) in the diagonal ostium with the mini-crush technique. (A) Optical
coherence tomography (OCT) image at 2-year follow-up shows good expansion of the BVS with homogeneous neointima. Proximal (A and B)
and distal (D) to the bifurcation, BVS struts seen on top of crushed EES struts (B and D) have been completely covered with neointima (yellow
arrows). (C) BVS struts previously jailing the Dg have completely disappeared. In the LMCA trifurcation lesion, a follow-up angiogram shows
restenosis in the distal LMCA (yellow arrow, yellow box). The yellow box shows a left anterior oblique cranial view of the distal LMCA. (E) At
2-year follow-up, EES struts on top of BVS struts are covered with thin neointima (yellow arrows). (F) OCT image reveals homogeneous pattern
of neointimal hyperplasia and late recoil of BVS (minimal scaffold area [MSA] 6.29 mm2). According to the IVUS ﬁndings, MSA was 6.11 mm2
(follow-up) versus 7.72 mm2 (after index procedure). (G and H) BVS struts previously jailing the left circumﬂex artery (LCX) and intermediate (IM)
branches have completely disappeared. OCT reveals the deformation of BVS struts superimposed on the calciﬁed plaque (F to H, *).
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618Follow-up OCT images clearly revealed the mech-
anism of in-scaffold restenosis (combination of neo-
intimal hyperplasia and late scaffold recoil) and
provided further insight in the treatment of bifurca-
tion lesions with the single crossover technique.
Disappearance of BVS struts jailing the side branch
ostia may reduce very late restenosis in this location
and facilitate very late side branch access should
new disease develop in the jailed vessel. This case
also demonstrates the importance of meticulous
lesion preparation with rotational atherectomy or
scoring balloon in case of BVS implantation for
calciﬁed lesions.Hiroyoshi Kawamoto, MD
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Balloon Catheter SizingBalloon underexpansion during percutaneous coro-
nary intervention is a major reason for stent under-
deployment, which occurs in part because the
predicted relationship between balloon pressure and
diameter is not always realized in vivo (1). We herein
describe a new device that accurately measures
balloon cross-sectional area (CSA) during inﬂation.
The CB catheter provides an accurate, real-time
digital display of the balloon CSA based on con-
tinuous electrical conductance recordings made
inside the balloon. Within each balloon, there are 4
radiopaque platinum-iridium electrodes mounted on
the catheter body. The 2 outer electrodes inject
a small and alternating electrical current (136 mApp,
FIGURE 1 CB Measurement Display and Balloon Usage In Vivo
(A) Numerical and running graphical display (x-axis is time) of
the size measurement for a 3.5-mm CB catheter on the console
and the corresponding (B) cine image in vivo in a swine left
circumﬂex artery. CSA ¼ cross-sectional area.
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61910 kHz) during inﬂation/deﬂation, and the 2 inner
electrodes make continuous voltage measure-
ments related to the local balloon size across an
approximate 3-mm cross-section at the center of
the balloon (i.e., a focal measurement is made at
the balloon center and is not averaged across the
entire balloon). When the CB catheter is connected
to a computer console, the local balloon CSA is
calculated and displayed in real time (Figure 1A)
based on Ohm’s law (CSA ¼ I  L/[s  V]), which
states that the 3-mm focal central balloon CSA
across the inner electrodes is equal to the known
constant current (I) times the known length be-
tween the electrodes (L) divided by the known
constant of the ﬂuid conductivity (s) and the
continuously measured voltage (V).
Validation of the CB catheter was ﬁrst completed
on the bench using randomized, repeat measure-
ments made in uniform plastic cylindrical phantoms
of known dimensions. The average CSA dif-
ference between the CB catheter measurements and
the true phantom dimension was 0.1  0.2 mm2
with an error of 2.6%. The average CSA dif-
ference on the bench between the repeat CB cath-
eter measurements was 0.0  0.1 mm2 with an error
of 1.6%.
Validation in vivo was completed in 5 domestic
swine (approximately 70 kg each). The CB catheter
studies were performed in 7 coronary vessels having
previous mild ﬁbrotic coronary injuries (CSA steno-
sis approximately 25%) and in 3 normal coronary
vessels. Manual measurement of the vessel area by
intravascular ultrasound (IVUS) (Eagle Eye coronary
catheter, Volcano Corporation, San Diego, Califor-
nia) was used to determine the vessel size before
stent deployment (8.2  3.8 mm2). Bare-metal
(Veriﬂex, Boston Scientiﬁc, Natick, Massachusetts)
or drug-eluting stents (Xience, Abbott Vascular,
Abbott Park, Illinois) were deployed at the
manufacturer-speciﬁed pressure (4.0 to 16.0 atm;
9.1 atm average) and diameter (2.8 to 4.5 mm;
3.4 mm average), with an IVUS-measured CSA of
7.8  2.9 mm2 versus an expected stent CSA of
9.4  4.1 mm2. A high-pressure CB catheter (poly-
ethylene terephthalate/nylon; fully inﬂated > 1 atm)
larger than the deployed stent diameter determined
by IVUS was selected and placed within the stent at
the same location as the IVUS, and at least 4 repeat
inﬂations/measurements (Figure 1B) were completed
(no difference between the ﬁrst and last CB mea-
surements). As expected for these noncompliant
balloons, the in vivo stent/vessel recoil (0.32 mm)
was almost identical to what is described in pub-
lished reports (0.28 mm) (1). The CB catheter had anaverage CSA of 10.9  3.4 mm2 versus a predicted
stent CSA of 9.4  4.1 mm2 and a post-deployment
IVUS CSA of 10.6  3.4 mm2 when recoil was
accounted for (1). The in vivo CSA measurement
accuracy bias (difference) versus post-procedural
IVUS when recoil was accounted for was 0.3  0.9
mm2 with an error of 8.5%. There were no observed
arrhythmias or deaths during any of the CB mea-
surement procedures.
The overall excellent CB catheter accuracy and
repeatability can be attributed to the fundamental
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620electrophysical law governing the catheter design
and the insulative nature of the balloon that gives
accurate results regardless of the electrical properties
of the surrounding environment. The CB catheter
offers accurate, real-time sizing capabilities com-
pletely independent of subjective user input and
allows the user to adjust the inﬂation instantaneously.
The CB sizing electrodes easily integrate into existing
standard coronary balloons and hence do not sig-
niﬁcantly alter clinical procedures. The CB catheter
functionality is ﬂexible and could easily be integrated
into other devices, such as stent delivery balloons,
drug-eluting balloons, and valvuloplasty balloons.
Future work will include a ﬁrst-in-man validation and
the use of multiple sets of measurement electrodes
inside the balloon to provide a balloon proﬁle showing
variation in the CSA dimension along the balloon
length.Mark C. Svendsen, PhD
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and ImportantI read with great interest the paper “Handheld
Ultrasound Versus Physical Examination in Patients
Referred for Transthoracic Echocardiography for a
Suspected Cardiac Condition” by Mehta et al. (1) and
the editorial comment by Marwick et al. (2) “Handheld
Ultrasound: Accurate Diagnosis at a Lower Cost?”.Handheld ultrasound (HHU) is very useful in clin-
ical diagnosis of suspected cardiac condition, but
there are limitations. How can one diagnose Heber-
den’s angina by HHU? It is necessary to take an
adequate history for diagnosis of angina.
Heart failure is a common and potentially lethal
condition. Admittedly, HHU can distinguish between
heart failure with reduced ejection fraction and
heart failure with preserved ejection fraction. How-
ever, the prognosis of these patients is related to the
severity of heart failure. New York Heart Association
(NYHA) functional classiﬁcation is an accepted
method to assess the severity of heart failure. I do
not believe that HHU can diagnose NYHA functional
class.
I believe that bedside clinical examination is less
expensive than transthoracic echocardiography (TTE)
or even the HHU device. It can be repeated as
frequently as necessary, and it is less expensive than
repeated TTE or HHU examination.
I can provide many more examples of limitations
and usefulness of both physical examination and
imaging studies.Kanu Chatterjee, MBBS*
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Still Necessary and ImportantWe agree with Dr. Chatterjee that history is key to
making a diagnosis. In our paper (1), we did not suggest
a substitution of history by handheld ultrasound
(HHU), but the substitution of the stethoscope. In re-
gard to heart failure, again it is a clinical diagnosis, as
Dr. Chatterjee rightly states, but HHU can differentiate
patients with reduced left ventricular (LV) systolic
function from those with “normal” LV function. It can
